SUN PHARMA: SIGNS U.S. MEDICINE PRICING & ACCESS AGREEMENT Sun Pharma… — ❁Stocks❁ ❁Result❁& BREAKING News

❁Stocks❁ ❁Result❁& BREAKING News@stocksresult · 21.5K subscribers Open in TelegramOpen

💊 SUN PHARMA: SIGNS U.S. MEDICINE PRICING & ACCESS AGREEMENT

Sun Pharma has signed an agreement with the U.S. government to improve access to affordable medicines.

• Will extend MFN pricing to U.S. state Medicaid programs

• MFN pricing also committed for future innovative medicine launches in the U.S.

• Section 232 tariffs delayed for over 2 years on innovative pharma products

• U.S. contributes around 27% of Sun Pharma’s global revenue

• Company remains focused on U.S. investments across R&D, manufacturing and sales

Sun Pharma also highlighted its proposed $11.75 billion EV acquisition of Organon.

t.me/stocksresult/45190